April 15th, 2021 – South San Francisco – Today, Cellares Co-Founder and CEO, Fabian Gerlinghaus was recognized in the 2021 Power List, celebrating the most Influential Medicine Makers of the past year.
The Medicine Maker 2021 Power List recognizes the inspirational minds that contribute to the development and manufacture of groundbreaking new medicines, including small molecules, biopharmaceuticals, and advanced therapies. The Medicine Maker has published its Power List annually since 2015.
Cellares Co-Founder and CEO, Fabian Gerlinghaus said, “I am very honored to have been selected by The Medicine Maker for their Power List 2021 in the field of advanced medicine, alongside other visionaries in cell and gene therapy. I’m particularly proud to be in the company of Jennifer Doudna, Bruce Levine, and immunotherapy pioneer, and Cellares board member Carl June, MD. This recognition is a reflection of the tireless efforts of our entire team at Cellares. Together, we are creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies.”
A link to the entire list can be found here.
About The Medicine Maker
The Medicine Maker is a leading publication for professionals in the fields of drug development and manufacturing. Through its many resources ̶ website, newsletters, webinars, social channels, monthly print magazine and videos ̶ The Medicine Maker gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network and further the field of small molecule, biologics, and advanced therapies development, manufacture and supply.